BLUESTOP MAX- external analgesic gel 
Clavel Corporation

----------

Blue Stop Max Roll-On

Active Ingredients

Lidocaine HCl 4%

Menthol 1%

Purpose

Topical Analgesic

Use

Temporary relief of pain

Warnings

For external use only

When using this product avoid contact with eyes

Stop use and ask a doctor if condition worsens or symptoms persist for more than 7 days or clear up and occur again within a few days.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Other Information

Store at room temperature

Avoid excessive hrat

Inactive Ingredients

Aloe Vera Leaf, Alpha-Tocopherol Acetate, Ammonium Acryloyldimethyltaurate, Dimethylacrylamide, Lauryl Methacrylate and Laureth-4 Methacrylate Copolymer, Trimethylolpropane Triacrylate Crosslinked (45000 Mpa.S), Cetyl Alcohol, Coconut Oil, Dimethyl Sulfone, Ethylhexylglycerin,Ethylhexyl Palmitate, Fragrance, Garcinia Indica Seed Butter, Glucosamine Sulfate, Glycerin, Melaleuca Alternifolia Leaf, Phenoxyethanol, Sodium Acrylate/Sodium Acryloyldimethyltaurate Copolymer (4000000 MW), Vitamin A Palmitate, Water, Witch Hazel

Questions or Comments

1-800-432-5464

Roll-On and Carton Labels

Roll-On Carton LabelRoll-On Label

BLUESTOP MAX 
external analgesic gel
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:82714-001
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
MENTHOL (UNII: L7T10EIP3A) (MENTHOL - UNII:L7T10EIP3A) MENTHOL10 mg  in 1 g
LIDOCAINE HYDROCHLORIDE (UNII: V13007Z41A) (LIDOCAINE - UNII:98PI200987) LIDOCAINE HYDROCHLORIDE ANHYDROUS40 mg  in 1 g
Inactive Ingredients
Ingredient NameStrength
WITCH HAZEL (UNII: 101I4J0U34)  
MELALEUCA ALTERNIFOLIA LEAF (UNII: G43C57162K)  
VITAMIN A PALMITATE (UNII: 1D1K0N0VVC)  
WATER (UNII: 059QF0KO0R)  
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
DIMETHYL SULFONE (UNII: 9H4PO4Z4FT)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
SODIUM ACRYLATE/SODIUM ACRYLOYLDIMETHYLTAURATE COPOLYMER (4000000 MW) (UNII: 1DXE3F3OZX)  
GARCINIA INDICA SEED BUTTER (UNII: US2H3D7800)  
GLUCOSAMINE SULFATE (UNII: 1FW7WLR731)  
CETYL ALCOHOL (UNII: 936JST6JCN)  
COCONUT OIL (UNII: Q9L0O73W7L)  
ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)  
ALOE VERA LEAF (UNII: ZY81Z83H0X)  
GLYCERIN (UNII: PDC6A3C0OX)  
ETHYLHEXYL PALMITATE (UNII: 2865993309)  
AMMONIUM ACRYLOYLDIMETHYLTAURATE, DIMETHYLACRYLAMIDE, LAURYL METHACRYLATE AND LAURETH-4 METHACRYLATE COPOLYMER, TRIMETHYLOLPROPANE TRIACRYLATE CROSSLINKED (45000 MPA.S) (UNII: Q7UI015FF9)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:82714-001-011 in 1 CARTON01/10/2023
185 g in 1 APPLICATOR; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01701/10/2023
Labeler - Clavel Corporation (927855643)
Establishment
NameAddressID/FEIBusiness Operations
TAKA USA Inc, dba Cosmetic Innovations802860515manufacture(82714-001)

Revised: 1/2024
Document Id: 0f0163ad-e4b9-6386-e063-6294a90ae2c3
Set id: f1efb51c-5217-4cb2-e053-2a95a90a7f95
Version: 3
Effective Time: 20240115
 
Clavel Corporation